The Decision To Enroll In Therapeutic Clinical Trials In A Pediatric Cancer Clinical Network
NCT05454618 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2026-05-20
Summary
The focus of this study is to learn about the factors that parents consider when making a decision for their child to participate or not in a clinical treatment research study.
Conditions
- Knowledge, Attitudes, Practice
Sponsors & Collaborators
-
St. Jude Children's Research Hospital
lead OTHER
Principal Investigators
-
Dylan Graetz, MD · St. Jude Children's Research Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-10-04
- Primary Completion
- 2027-06-30
- Completion
- 2027-06-30
Countries
- United States
Study Locations
More Related Trials
-
Therapy for Pediatric Hodgkin Lymphoma
NCT00145600 ·Status: COMPLETED ·Phase: PHASE2
-
Learning Impairments Among Survivors of Childhood Cancer
NCT00576472 ·Status: COMPLETED ·Phase: PHASE4
-
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
NCT05535166 ·Status: RECRUITING ·Phase: PHASE2
-
Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
NCT00002485 ·Status: COMPLETED
-
Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors
NCT00042367 ·Status: COMPLETED ·Phase: NA
-
Establishment of a Lifetime of Cohort of Adults Surviving Childhood Cancer
NCT00760656 ·Status: RECRUITING
-
B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021
NCT05518383 ·Status: RECRUITING ·Phase: PHASE4
-
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
NCT02847130 ·Status: COMPLETED
-
Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia
NCT00186875 ·Status: COMPLETED ·Phase: PHASE2
-
Therapy for Children With Neuroblastoma
NCT00135135 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas
NCT02130869 ·Status: COMPLETED ·Phase: PHASE1
-
Decision Aid for Education and Support About Cancer Treatment
NCT06191679 ·Status: COMPLETED ·Phase: NA
-
Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma
NCT01700946 ·Status: COMPLETED ·Phase: PHASE2
-
Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia
NCT00085176 ·Status: COMPLETED
-
The PediQUEST Study: Evaluation of Pediatric Quality of Life and Evaluation of Symptoms Technology
NCT01838564 ·Status: COMPLETED ·Phase: NA
-
Parental Decision-Making for Children With Relapsed Neuroblastoma
NCT02282735 ·Status: ACTIVE_NOT_RECRUITING
-
Study for Treatment of Cancer in Children With Ataxia-telangiectasia
NCT00187057 ·Status: COMPLETED ·Phase: NA
-
Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease
NCT00004010 ·Status: COMPLETED ·Phase: PHASE2
-
Informed Consent in Pediatric Cancer Trials
NCT00923650 ·Status: COMPLETED
-
Feasibility of Screening for Early Late Effects of Contemporary Therapy in High-Risk Neuroblastoma Survivors
NCT06480526 ·Status: ACTIVE_NOT_RECRUITING
-
Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL
NCT00187161 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma
NCT00025064 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma
NCT00003423 ·Status: UNKNOWN ·Phase: PHASE3
-
Radiation Therapy and the Natural History of Childhood Cancers
NCT00064883 ·Status: COMPLETED
-
Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma
NCT00091091 ·Status: COMPLETED